1-naphthylamine has been researched along with Aura in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dailey, JW; Jobe, PC; Yan, QS | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| Gerner, R; Kaufman, KR | 1 |
3 other study(ies) available for 1-naphthylamine and Aura
| Article | Year |
|---|---|
Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.
Topics: 1-Naphthylamine; Acoustic Stimulation; Animals; Epilepsy; Extracellular Space; Hydroxyindoleacetic Acid; Male; Microdialysis; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thalamus | 1995 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Lamotrigine toxicity secondary to sertraline.
Topics: 1-Naphthylamine; Adolescent; Adult; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Lamotrigine; Metabolic Clearance Rate; Neurocognitive Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazines | 1998 |